Clinical Trials Logo

Filter by:
NCT ID: NCT05131217 Completed - Aging Well Clinical Trials

Effects of Acute Exercise Intensity on Cerebral Blood Flow and Cognitive Function in Older Adults

Start date: January 14, 2022
Phase: N/A
Study type: Interventional

This study will analyze the influence of acute bout exercise intensities (continuous moderate and HIIT) on middle cerebral artery velocity (MCAv) to identify which intensity elicits the greatest increase in CBF in older adults (65+ yrs). Additionally, this study will help verify positive correlations between MCAv and cognitive function. These findings are important in determining the optimal exercise prescription for increased resilience against the age-related cognitive degradation.

NCT ID: NCT05130970 Completed - Clinical trials for Idiopathic Pulmonary Fibrosis

CSL312 Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

Start date: January 27, 2022
Phase: Phase 2
Study type: Interventional

This is a prospective, phase 2a, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of CSL312 in subjects with idiopathic pulmonary fibrosis (IPF).

NCT ID: NCT05130905 Completed - Healthy Nutrition Clinical Trials

RiteStart Personal Nutritional Dietary Study

RESPOND
Start date: September 1, 2017
Phase: N/A
Study type: Interventional

This study is undertaken to explore the effects of a bovine colostrum containing MVM (RiteStart) on different health aspects by quantitatively assessing relevant serum and saliva biomarkers, over a 12-week period in participants.

NCT ID: NCT05130593 Completed - Diabetes Prevention Clinical Trials

Pilot Study Evaluating the Acceptability and Absorption of the Bioactive Compounds of a Russian Tarragon Nutrasorb Bar

Start date: October 25, 2021
Phase:
Study type: Observational

The purpose of this study is to make a bar from the soy-protein Russian Tarragon complex (PMI-5011/Nutrasorb) that is safe and acceptable for consumption, and to test the blood levels of plasma bioactive (DMC-2) after ingestion of the bar. The PMI-5011/Nutrasorb comes from a plant source called Artemisia dracunculus. This plant has a long history of medicinal (health) and culinary (food) use and has been reported as effective as a traditional treatment for diabetes in various parts of the world.

NCT ID: NCT05130541 Completed - Covid19 Clinical Trials

Proning Early in Awake COVID-19 Hypoxic Respiratory Failure (PREACHR) Study

PREACHR
Start date: June 1, 2020
Phase: N/A
Study type: Interventional

The aim of this proposal is to study whether proning, a technique that has previously been shown to improve lung function in patients with acute respiratory distress syndrome (ARDS), can prevent those with mild to moderate symptoms of COVID-19 from progressing to severe disease when initiated early, thereby averting intubation, reducing hospitalization, and, ultimately, decreasing mortality.

NCT ID: NCT05130411 Completed - Clinical trials for Sexual Desire Disorder

An Exploratory Investigation to Identify if Dame Product's "DLM" Works to Improve Sexual Desire and Mood in Females

Start date: October 15, 2021
Phase: N/A
Study type: Interventional

This is a single-group, non-randomized, non-controlled, open-label observational trial to study and evaluate the efficacy of a commercial dietary supplement, called "DLM" ("test product"). It is hypothesized that the test product, which is designed as an edible gummy, will present a favorable result to increase sexual desire and improve mood.

NCT ID: NCT05130307 Completed - Pain, Acute Clinical Trials

Virtual Reality Analgesia for Brief Thermal Pain

Start date: April 25, 2022
Phase: N/A
Study type: Interventional

Using immersive virtual reality as a form of pain distraction during a brief "painful but tolerable" temperature.

NCT ID: NCT05130281 Completed - Clinical trials for Anxiety Disorders and Symptoms

Mobile Cognitive Behavior Therapy Targeting Anxiety Disorders

Start date: June 18, 2021
Phase: N/A
Study type: Interventional

This study aims to examine different ways of motivating people to make use of Maya, a mobile cognitive behavior therapy (CBT) program for adolescents and young adults experiencing anxiety symptoms, and to assess whether social supports are as efficacious, or more efficacious, than other non-monetary incentives. Subjects will use the Maya app for at least 20 minutes per day, 2 days per week, for 6 weeks. Assessments will include a weekly check in with a member of the research team, questionnaires, and an optional magnetic resonance imaging (MRI) recording.

NCT ID: NCT05130229 Completed - Pediatric Sleep Clinical Trials

Community Partnership for Healthy Sleep: Sleep Well, Bee Well Part 2

Start date: March 8, 2022
Phase: N/A
Study type: Interventional

Using a pragmatic cluster randomized trial, this study aims to examine the feasibility, and acceptability of a 3-week behavioral sleep intervention, Sleep Well, Bee Well (SWBW), and to test the preliminary efficacy of SWBW compared to a wait-list control with children ages 1-2.5 years old at two Early Head Start (EHS) centers on toddler sleep characteristics and parent wellbeing.

NCT ID: NCT05130073 Completed - Clinical trials for Anal Squamous Cell Carcinoma

4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer

Start date: July 31, 2019
Phase:
Study type: Observational

This study determines whether a positron emission tomography (PET)/computed tomography (CT) 4-point scoring system may predict overall survival for anal squamous cell cancer patients. A 4-point scoring system involving imaging scans may help to predict how patients with anal squamous cell cancer respond to chemoradiation therapy.